High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6

Clinical and Experimental Allergy

Volumn 45, Issue 5, 2015, Pages 928-939

  Orivuori, L ^a,b   Mustonen, K ^b   de Goffau, M C ^c   Hakala, S ^b   Paasela, M ^b   Roduit, C ^d,e   Dalphin, J C ^f   Genuneit, J ^g   Lauener, R ^d,h   Riedler, J ⁱ   Weber, J ^j   von Mutius, E ^j,k   Pekkanen, J ^b   Harmsen, H J M ^c   Vaarala, O ^a,l   Hirvonen, Maija Riitta ^m   Hyvärinen, Anne ^b   Karvonen, Anne M ^b   Remes, Sami ^b   Roponen, Marjut ⁿ   Tiittanen, Pekka ^b   Dalphin, Marie Laure ^f   Kaulek, Vincent ^f   Depner, Martin ^g   Ege, Markus ^j   Illi, Sabina ^j   Kabesch, Michael ^o   Pfefferle, Petra ^p   Renz, Harald ^p   Schaub, Bianca ^j   Doekes, Gert ^q   Braun Fahrländer, Charlotte ^r,s   Frei, Remo ^e   Loss, Georg ^j,r,s   more..

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d CHRISTINE KÜHNE CENTER FOR ALLERGY RESEARCH AND EDUCATION CK CARE   (Switzerland)

^e UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^f UNIVERSITY HOSPITAL OF BESANÇON   (France)

^g UNIVERSITY OF ULM   (Germany)

^h Children's Hospital of Eastern Switzerland   (Switzerland)

ⁱ Children's Hospital   (Austria)

^j LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^k Member of the German Center for Lung Research ^*  (Sweden)

^l ASTRAZENECA R AND D   (Sweden)

^m UNIVERSITY OF EASTERN FINLAND   (Finland)

ⁿ KUOPIO UNIVERSITY HOSPITAL   (Finland)

^o UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^p PHILIPPS UNIVERSITY MARBURG   (Germany)

^q UTRECHT UNIVERSITY   (Netherlands)

^r SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^s UNIVERSITY OF BASEL   (Switzerland)

more..

Author keywords

Escherichia; Asthma; Atopic dermatitis; Children; Colonization; Farming; Fecal calprotectin; Lactobacillaceae; Lipopolysaccharide

Indexed keywords

CALGRANULIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN E; INTERLEUKIN 10; RNA 16S; BIOLOGICAL MARKER;

AGE DISTRIBUTION; AGRICULTURAL WORKER; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BRONCHITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENTERITIS; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES LEVEL; FECES MICROFLORA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; INFANT; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PREDICTION; PRIORITY JOURNAL; PYROSEQUENCING; QUESTIONNAIRE; UPREGULATION; AGE; BACTERIUM; CHEMISTRY; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; DERMATITIS, ATOPIC; FECES; HYPERSENSITIVITY; IMMUNOLOGY; INTESTINAL DISEASES; METABOLISM; MONONUCLEAR CELL; MULTICENTER STUDY; ODDS RATIO; PREGNANCY; PRESCHOOL CHILD; RISK FACTOR;

AGE FACTORS; ASTHMA; BACTERIA; BIOMARKERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DERMATITIS, ATOPIC; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; HYPERSENSITIVITY; INFANT; INTERLEUKIN-10; INTESTINAL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; LEUKOCYTES, MONONUCLEAR; MALE; ODDS RATIO; PREGNANCY; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84927760544     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12522     Document Type: Article

References (47)

1. Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005; 307:1920-5.
2. Kosiewicz MM, Dryden GW, Chhabra A, Alard P. Relationship between gut microbiota and development of T cell associated disease. FEBS Lett 2014; 588:4195-206.
3. Wlasiuk G, Vercelli D. The farm effect, or: when, what and how a farming environment protects from asthma and allergic disease. Curr Opin Allergy Clin Immunol 2012; 12:461-6.
4. Johne B, Fagerhol MK, Lyberg T et al. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 1997; 50:113-23.
5. Kapel N, Campeotto F, Kalach N, Baldassare M, Butel MJ, Dupont C. Faecal calprotectin in term and preterm neonates. J Pediatr Gastroenterol Nutr 2010; 51:542-7.
6. Dale I, Lagerhol MK, Naesgaard I. Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. Eur J Biochem 1983; 134:1-6.
7. Stríz I, Trebichavský I. Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res 2004; 53:245-53.
8. Canani R, Terrin G, Rapacciuolo L et al. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Dig Liver Dis 2008; 40:547-53.
9. Inoue K, Aomatsu T, Yoden A, Okuhira T, Kaji E, Tamai H. Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases. J Gastroenterol Hepatol 2014; 29:1406-12.
10. Ertekin V, Selimoğlu MA, Turgut A, Bakan N. Fecal calprotectin concentration in celiac disease. J Clin Gastroenterol 2010; 44:544-6.
11. Andrés Cerezo L, Mann H, Pecha O et al. Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther 2011; 13:R122.
12. Beser ÖF, Sancak S, Erkan T, Kutlu T, Çokugras H, Çokugras F. Can fecal calprotectin level be used as a markers of inflammation in the diagnosis and follow-up of cow's milk protein allergy? Allergy Asthma Immunol Res 2014; 6:33-8.
13. Rugtveit J, Fagerhol MK. Age-dependent variations in fecal calprotectin concentrations in children. J Pediatr Gastroenterol Nutr 2002; 34:323.
14. Baldassarre ME, Altomare MA, Fanelli M et al. Does calprotectin represent a regulatory factor in host defense or a drug target in inflammatory disease? Endocr Metab Immune Disord Drug Targets 2007; 7:1-5.
15. Walker WA. Gastrointestinal host defence: importance of gut closure in control of macromolecular transport. Ciba Found Symp 1979; 70:201-19.
16. Josefsson S, Bunn SK, Domellöf M. Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr 2007; 44:407-13.
17. von Mutius E, Schmid S; PASTURE Study Group. The PASTURE project: EU support for the improvement of knowledge about risk factors and preventive factors for atopy in Europe. Allergy 2006; 61:407-13.
18. Riedler J, Braun-Fahrländer C, Eder W et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 2001; 358:1129-33.
19. Ferris BG. Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis 1978; 118:1-120.
20. Basagaña X, Torrent M, Atkinson W et al. Domestic aeroallergen levels in Barcelona and Menorca (Spain). Pediatr Allergy Immunol 2002; 13:412-7.
21. Alfvén T, Braun-Fahrländer C, Brunekreef B et al. Allergic diseases and atopic sensitization in children related to farming and anthroposophic lifestyle - the PARSIFAL study. Allergy 2006; 61:414-21.
22. Orivuori L, Loss G, Roduit C et al. Soluble immunoglobulin A in breast milk is inversely associated with atopic dermatitis at early age: The PASTURE cohort study. Clin Exp Allergy 2014; 44:102-12.
23. Yu Z, Morrison M. Improved extraction of PCR-quality community DNA from digesta and fecal samples. Biotechniques 2004; 36:808-12.
24. van den Bogert B, de Vos W, Zoetendal E, Kleerebezem M. Microarray analysis and barcoded pyrosequencing provide consistent microbial profiles depending on the source of human intestinal samples. Appl Environ Microbiol 2011; 77:2071-80.
25. Wu GD, Lewis JD, Hoffmann C et al. Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags. BMC Microbiol 2010; 10:206.
26. De Filippo C, Cavalieri D, Di Paola M et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010; 107:14691-969.
27. Goecks J, Nekrutenko A, Taylor J; Galaxy Team. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol 2010; 11:R86.
28. Cole JR, Wang Q, Cardenas E et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 2009; 37(Database issue):D141-5.
29. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 2007; 73:5261-7.
30. Ludwig W, Strunk O, Westram R et al. ARB: a software environment for sequence data. Nucleic Acids Res 2004; 32:1363-71.
31. Pruesse E, Quast C, Knittel K, Fuchs BM, Peplies J, Glöckner FO. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res 2007; 35:7188-96.
32. Fagerberg UL, Lööf L, Merzoug RD, Hansson LO, Finkel Y. Fecal calprotectin levels in healthy children studied with an improved assay. J Pediatr Gastroenterol Nutr 2003; 37:468-72.
33. Gueimonde M, Laitinen K, Salminen S, Isolauri E. Breast milk: a source of bifidobacteria for infant gut development and maturation? Neonatology 2007; 92:64-6.
34. Hornef MW, Frisan T, Vandewalle A, Normark S, Richter-Dahlfors A. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med 2002; 195:559-70.
35. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003; 197:403-11.
36. Manuzak J, Dillon S, Wilson C. Differential interleukin-10 (IL-10) and IL-23 production by human blood monocytes and dendritic cells in response to commensal enteric bacteria. Clin Vaccine Immunol 2012; 19:1207-17.
37. Bortolatto J, Borducchi É, Rodriguez D et al. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis. Clin Exp Allergy 2008; 38:1668-79.
38. Rodríguez D, Keller AC, Faquim-Mauro EL et al. Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J Immunol 2003; 171:1001-8.
39. Chung S-, Choi SH, Cho KJ, C- Joo. Toll-like receptor 4 signalling attenuates experimental allergic conjunctivitis. Clin Exp Immunol 2011; 164:275-81.
40. Jiao L, Han X, Wang S et al. Imprinted DC mediate the immune-educating effect of early-life microbial exposure. Eur J Immunol 2009; 39:469-80.
41. Christensen HR, Frøkiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002; 168:171-8.
42. Hessle C, Hanson LA, Wold AE. Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin Exp Immunol 1999; 116:276-82.
43. Pohjavuori E, Viljanen M, Korpela R et al. Lactobacillus GG effect in increasing IFN-γ production in infants with cow's milk allergy. J Allergy Clin Immunol 2004; 114:131-6.
44. 2 production in species of the Lactobacillus acidophilus group: a central role for a novel NADH-dependent flavin reductase. Appl Environ Microbiol 2014; 80:2229-39.
45. Marschan E, Kuitunen M, Kukkonen K et al. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 2008; 38:611-8.
46. Asher MI, Keil U, Anderson HR et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8:483-91.
47. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186:23-31.